Katherine Robinson, PharmD, MS, BCPS

Katherine Robinson, PharmD, MS, BCPS

  • Clinical Pharmacy Specialist

Departments

Board Certification

  • Board Certified Pharmacotherapy Specialist 

Education

  • BS – Rhodes College, Memphis, TN
  • PharmD – University of Tennessee Health Science Center, Memphis, TN
  • MS – University of Pittsburgh School of Pharmacy, Pittsburgh, PA

Post-Graduate Training

  • PGY1 Pharmacy Residency – UK HealthCare
  • PGY2 Clinical Pharmacogenomics Residency – St. Jude Children’s Research Hospital
  • Fellowship – University of Pittsburgh School of Pharmacy

Focused Area of Practice

  • Pediatric Cancer Survivorship

Honors/Awards

  • Inter-Society for Coordinating Committee for Practitioner Education in Genomics Scholar Award

Research Interest

  • Pharmacogenomics and Precision Medicine
  • Implementation Science
  • Long-term Complications of Chemotherapy

Pharmacy Organizations/Committee Service

  • Pharmacogenomics Global Research Network (PGRN) Implementation Group

Contact Information

Katherine Robinson, PharmD, MS, BCPS Pharmaceutical Services St. Jude Children's Research Hospital 262 Danny Thomas Place Memphis, TN 38105-3678

Selected Publications

Robinson KM, Eum S, Desta Z, et al. Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2B6 Genotype and Methadone Therapy. Clin Pharmacol Ther 2024. Doi:10.1002/cpt.3338

Robinson KM, Yang W, Haidar CE, et al. Concordance between glucose-6-phosphate dehydrogenase (G6PD) genotype and phenotype and rasburicase use in patients with hematologic malignancies. Pharmacogenomics J 2019; 19(3): 305-14

Robinson KM, Yang W, Karol SE, et al. No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapy. Pediatr Blood Cancer 2019; 66(6):e27681. 

Last update: October 2024

Close
Close